<mods:mods xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" version="3.3" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><mods:titleInfo><mods:title>TIBBIYOTDA DNK REKOMBINANTLARNI QO‘LLANILISHI. VIRUSLARGA VA O‘SMALARGA QARSHI DORI VOSITALARNI TA’SIR MEXANIZMI</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Rohilabonu</mods:namePart><mods:namePart type="family">Panjiyeva</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Aziza</mods:namePart><mods:namePart type="family">Djurakulova</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>Maqolada tibbiyotda DNK rekombinant texnologiyalarining qo‘llanilishi, ularning dori vositalarining ishlab chiqarishidagi o‘rni, shuningdek, viruslarga va o‘smalarga qarshi dori vositalarining ta’sir mexanizmlari ko‘rib chiqilgan. Rekombinant DNK texnologiyalari asosida ishlab chiqarilgan biologik preparatlar kasalliklarni aniq nishonga olish va davolashda samaradorligini oshirmoqda. Tadqiqot natijalari ushbu usullarni kengaytirish imkoniyatlarini ko‘rsatadi</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2024-12-29</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>Research Science and Innovation House</mods:publisher></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>